Clinical trial
CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency
NCT06183736
Study timeline
Study start (estimated)2023-12-20Date precision: day
Registry last updated2023-12-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Solid Tumorsunresolved
Interventions
CVL237 tabletsDRUG
Sponsors & collaborators
Convalife (Shanghai) Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06183736 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.